ABBOTT LABORATORIES·4

May 3, 6:12 PM ET

OSBORN WILLIAM A 4

4 · ABBOTT LABORATORIES · Filed May 3, 2022

Insider Transaction Report

Form 4
Period: 2022-04-29
Transactions
  • Award

    Common shares without par value

    2022-04-29+1,60298,598 total
  • Award

    Option (right to buy)

    2022-04-29+8,1068,106 total
    Exercise: $115.46From: 2022-04-29Exp: 2032-04-28Common Shares (8,106 underlying)
Footnotes (2)
  • [F1]These are restricted stock units awarded under the Abbott Laboratories 2017 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program).
  • [F2]Stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.

Documents

1 file
  • 4
    form4-05032022_030503.xmlPrimary